BioPharmSignal logoBioPharmSignal

Biotech News

GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications

GoodRx (GDRX)GoodRxPartnership

Collaboration expands access to trusted therapies with discounted cash prices for leading brands including Lipitor®, Celebrex®, Viagra®, and Norvasc® SANTA MONICA, Calif. --(BUSINESS WIRE)--Mar. 11, 2026-- GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today

Related news

GDRXGoodRx2026-02-06 00:44 EST

GoodRx Powers Pricing for Leading Brand Medications on TrumpRx

GDRXGoodRx2026-09-03 13:00 EST

From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household

View all latest news

GoodRx

Medication-Savings Platform GoodRx is a U.S. digital platform that helps consumers compare prescription prices and access discounts at pharmacies. Consumer and Provider Network The service connects consumers, pharmacies, pharmacy-benefit managers, manufacturers and healthcare professionals. Users access savings through the website,...

Recent company news

GDRXGoodRx2026-10-29 13:15 EST

GoodRx Launches Employer Direct Weight Loss Offering

GDRXGoodRx2026-09-03 13:00 EST

From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household

GDRXGoodRx2026-08-05 20:05 EST

GoodRx Reports Second Quarter 2026 Results

GDRXGoodRx2026-07-09 20:05 EST

GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call

GDRXGoodRx2026-05-27 13:00 EST

GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs

Stock data

Close
3.49 USD
Market cap
999.09M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States